LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature.

    Bruni, Valentina / Roppa, Katia / Scionti, Francesca / Apa, Rosalbina / Sestito, Simona / Di Martino, Maria T / Pensabene, Licia / Concolino, Daniela

    Cytogenetic and genome research

    2019  Volume 158, Issue 2, Page(s) 74–82

    Abstract: Deletion of distal 9p is associated with a rare clinical condition characterized by dysmorphic features, developmental delay, and ambiguous genitalia. The phenotype shows variable expressivity and is related to the size of the deletion. 8q24 duplication ... ...

    Abstract Deletion of distal 9p is associated with a rare clinical condition characterized by dysmorphic features, developmental delay, and ambiguous genitalia. The phenotype shows variable expressivity and is related to the size of the deletion. 8q24 duplication has been reported in only few cases to date, all showing dysmorphic features and mild psychomotor developmental delay. A case of chromosomal aberration involving a 9p terminal deletion with an 8q duplication has never been reported. Here, we describe a child with a female phenotype, male karyotype, dysmorphic features, ambiguous genitalia, and developmental delay. In order to assess the cause of the patient's phenotype, conventional karyotyping, FISH, and a chromosomal microarray analysis were performed on the patient and her parents. The cytogenetic and molecular analysis revealed an unbalanced chromosomal aberration with a duplication in the long arm of chromosome 8 at 8q24.11q24.3 associated with a distal deletion in the short arm of chromosome 9 at 9p24.3p24.1, derived from a maternal balanced translocation. We compared the clinical picture of our patient with other similar cases reported in the literature and found that some clinical findings, such as strabismus, symphalangism of the first finger, and cubitus valgus, have never been previously associated with 9p deletion or 8q duplication expanding the phenotypic range of this condition. This study is aimed to better define the clinical history and prognosis of patients with this rare chromosomal aberration.
    MeSH term(s) Chromosome Deletion ; Chromosome Mapping ; Chromosomes, Human, Pair 8/genetics ; Chromosomes, Human, Pair 9/genetics ; Developmental Disabilities/genetics ; Female ; Gonadal Dysgenesis, 46,XY/genetics ; Humans ; Trisomy/genetics
    Language English
    Publishing date 2019-05-28
    Publishing country Switzerland
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 2087824-2
    ISSN 1424-859X ; 1424-8581
    ISSN (online) 1424-859X
    ISSN 1424-8581
    DOI 10.1159/000500619
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.

    Di Mauro, Stefania / Scamporrino, Alessandra / Petta, Salvatore / Urbano, Francesca / Filippello, Agnese / Ragusa, Marco / Di Martino, Maria T / Scionti, Francesca / Grimaudo, Stefania / Pipitone, Rosaria M / Privitera, Graziella / Di Pino, Antonino / Scicali, Roberto / Valenti, Luca / Dongiovanni, Paola / Fracanzani, Anna / Rabuazzo, Agata M / Craxì, Antonio / Purrello, Michele /
    Purrello, Francesco / Piro, Salvatore

    Liver international : official journal of the International Association for the Study of the Liver

    2019  Volume 39, Issue 9, Page(s) 1742–1754

    Abstract: Background & aims: In patients with non-alcoholic fatty liver disease (NAFLD), liver biopsy is the gold standard to detect non-alcoholic steatohepatitis (NASH) and stage liver fibrosis. We aimed to identify differentially expressed mRNAs and non-coding ... ...

    Abstract Background & aims: In patients with non-alcoholic fatty liver disease (NAFLD), liver biopsy is the gold standard to detect non-alcoholic steatohepatitis (NASH) and stage liver fibrosis. We aimed to identify differentially expressed mRNAs and non-coding RNAs in serum samples of biopsy-diagnosed mild and severe NAFLD patients with respect to controls and to each other.
    Methods: We first performed a whole transcriptome analysis through microarray (n = 12: four Control: CTRL; four mild NAFLD: NAS ≤ 4 F0; four severe NAFLD NAS ≥ 5 F3), followed by validation of selected transcripts through real-time PCRs in an independent internal cohort of 88 subjects (63 NAFLD, 25 CTRL) and in an external cohort of 50 NAFLD patients. A similar analysis was also performed on liver biopsies and HepG2 cells exposed to oleate:palmitate or only palmitate (cellular model of NAFL/NASH) at intracellular/extracellular levels. Transcript correlation with histological/clinical data was also analysed.
    Results: We identified several differentially expressed coding/non-coding RNAs in each group of the study cohort. We validated the up-regulation of UBE2V1, BNIP3L mRNAs, RP11-128N14.5 lncRNA, TGFB2/TGFB2-OT1 coding/lncRNA in patients with NAS ≥ 5 (vs NAS ≤ 4) and the up-regulation of HBA2 mRNA, TGFB2/TGFB2-OT1 coding/lncRNA in patients with Fibrosis stages = 3-4 (vs F = 0-2). In in vitro models: UBE2V1, RP11-128N14.5 and TGFB2/TGFB2-OT1 had an increasing expression trend ranging from CTRL to oleate:palmitate or only palmitate-treated cells both at intracellular and extracellular level, while BNIP3L was up-regulated only at extracellular level. UBE2V1, RP11-128N14.5, TGFB2/TGFB2-OT1 and HBA2 up-regulation was also observed at histological level. UBE2V1, RP11-128N14.5, BNIP3L and TGFB2/TGFB2-OT1 correlated with histological/biochemical data. Combinations of TGFB2/TGFB2-OT1 + Fibrosis Index based on the four factors (FIB-4) showed an Area Under the Curve (AUC) of 0.891 (P = 3.00E-06) or TGFB2/TGFB2-OT1 + Fibroscan (AUC = 0.892, P = 2.00E-06) improved the detection of F = 3-4 with respect to F = 0-2 fibrosis stages.
    Conclusions: We identified specific serum coding/non-coding RNA profiles in severe and mild NAFLD patients that possibly mirror the molecular mechanisms underlying NAFLD progression towards NASH/fibrosis. TGFB2/TGFB2-OT1 detection improves FIB-4/Fibroscan diagnostic performance for advanced fibrosis discrimination.
    MeSH term(s) Adult ; Biomarkers/blood ; Biopsy ; Cohort Studies ; Disease Progression ; Female ; Gene Expression Profiling ; Humans ; Liver/enzymology ; Liver/pathology ; Liver Cirrhosis/blood ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Male ; Middle Aged ; Non-alcoholic Fatty Liver Disease/blood ; Non-alcoholic Fatty Liver Disease/diagnosis ; Non-alcoholic Fatty Liver Disease/pathology ; Predictive Value of Tests ; RNA, Untranslated/blood ; ROC Curve ; Severity of Illness Index
    Chemical Substances Biomarkers ; RNA, Untranslated
    Language English
    Publishing date 2019-06-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2102783-3
    ISSN 1478-3231 ; 1478-3223
    ISSN (online) 1478-3231
    ISSN 1478-3223
    DOI 10.1111/liv.14167
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: EDTA is essential to recover lead from dried blood spots on filter paper.

    Di Martino, Maria T / Michniewicz, Andzelika / Martucci, Maria / Parlato, Giuseppe

    Clinica chimica acta; international journal of clinical chemistry

    2004  Volume 350, Issue 1-2, Page(s) 143–150

    Abstract: Background: Residual dried blood spots (DBSs) on filter paper from neonatal screening have been proposed as samples for population survey of lead contamination. We have investigated the EDTA effect on lead release in the eluting solution.: Methods: ... ...

    Abstract Background: Residual dried blood spots (DBSs) on filter paper from neonatal screening have been proposed as samples for population survey of lead contamination. We have investigated the EDTA effect on lead release in the eluting solution.
    Methods: Furnace atomic absorption spectrophotometry has been used for lead measurements. Standard, blank and sample solutions contained 2% m/v NH(4)H(2)PO(4), 0.5% v/v Triton X-100 and 0.2% v/v HNO(3) as matrix modifier solution (MMS) with or without EDTA. A calibration curve was established from aqueous standard solutions. Paper discs from DBS and blank, punched near the DBS, were eluted in MM solution and, where required, EDTA at different concentrations. Specimens were leftover DBSs with different storage times, matched samples from 20 adult patients consisting of liquid whole blood (LWB) containing 5 mmol/L EDTA, DBSs eluted in MM solution with 5 mmol/L EDTA or without EDTA.
    Results: Optimal lead recovery from DBS required 5 mM EDTA in the eluting solution. Mean lead levels of LWB and DBSs eluted with EDTA were similar and higher than DBSs without EDTA (P<0.001). Without EDTA, the median value of lead optical density was lower for 6-month-old DBSs than for blanks (P<0.001).
    Conclusions: Residual DBSs can be used for population survey, but 5 mmol/L EDTA in the extracting solution is required to fully recover lead.
    MeSH term(s) Adult ; Blood Stains ; Edetic Acid/chemistry ; Humans ; Infant, Newborn ; Lead/blood ; Neonatal Screening ; Paper ; Spectrophotometry, Atomic
    Chemical Substances Lead (2P299V784P) ; Edetic Acid (9G34HU7RV0)
    Language English
    Publishing date 2004-12
    Publishing country Netherlands
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80228-1
    ISSN 1873-3492 ; 0009-8981
    ISSN (online) 1873-3492
    ISSN 0009-8981
    DOI 10.1016/j.cccn.2004.07.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.

    Leone, Emanuela / Morelli, Eugenio / Di Martino, Maria T / Amodio, Nicola / Foresta, Umberto / Gullà, Annamaria / Rossi, Marco / Neri, Antonino / Giordano, Antonio / Munshi, Nikhil C / Anderson, Kenneth C / Tagliaferri, Pierosandro / Tassone, Pierfrancesco

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2013  Volume 19, Issue 8, Page(s) 2096–2106

    Abstract: Purpose: Deregulated expression of miRNAs plays a role in the pathogenesis and progression of multiple myeloma. Among upregulated miRNAs, miR-21 has oncogenic potential and therefore represents an attractive target for the treatment of multiple myeloma.! ...

    Abstract Purpose: Deregulated expression of miRNAs plays a role in the pathogenesis and progression of multiple myeloma. Among upregulated miRNAs, miR-21 has oncogenic potential and therefore represents an attractive target for the treatment of multiple myeloma.
    Experimental design: Here, we investigated the in vitro and in vivo anti-multiple myeloma activity of miR-21 inhibitors.
    Results: Either transient-enforced expression or lentivirus-based constitutive expression of miR-21 inhibitors triggered significant growth inhibition of primary patient multiple myeloma cells or interleukin-6-dependent/independent multiple myeloma cell lines and overcame the protective activity of human bone marrow stromal cells. Conversely, transfection of miR-21 mimics significantly increased proliferation of multiple myeloma cells, showing its tumor-promoting potential in multiple myeloma. Importantly, upregulation of miR-21 canonical validated targets (PTEN, Rho-B, and BTG2), together with functional impairment of both AKT and extracellular signal-regulated kinase signaling, were achieved by transfection of miR-21 inhibitors into multiple myeloma cells. In vivo delivery of miR-21 inhibitors in severe combined immunodeficient mice bearing human multiple myeloma xenografts expressing miR-21 induced significant antitumor activity. Upregulation of PTEN and downregulation of p-AKT were observed in retrieved xenografts following treatment with miR-21 inhibitors.
    Conclusion: Our findings show the first evidence that in vivo antagonism of miR-21 exerts anti-multiple myeloma activity, providing the rationale for clinical development of miR-21 inhibitors in this still incurable disease.
    MeSH term(s) Animals ; Blotting, Western ; Cell Line, Tumor ; Cell Proliferation ; Cell Survival/genetics ; Cells, Cultured ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Immediate-Early Proteins/genetics ; Immediate-Early Proteins/metabolism ; Male ; Mice ; Mice, SCID ; MicroRNAs/genetics ; Multiple Myeloma/genetics ; Multiple Myeloma/pathology ; Multiple Myeloma/therapy ; PTEN Phosphohydrolase/genetics ; PTEN Phosphohydrolase/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; RNA, Antisense/administration & dosage ; RNA, Antisense/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Transfection ; Tumor Cells, Cultured ; Tumor Suppressor Proteins/genetics ; Tumor Suppressor Proteins/metabolism ; Xenograft Model Antitumor Assays ; rhoB GTP-Binding Protein/genetics ; rhoB GTP-Binding Protein/metabolism
    Chemical Substances Immediate-Early Proteins ; MIRN21 microRNA, human ; MicroRNAs ; RNA, Antisense ; Tumor Suppressor Proteins ; BTG2 protein, human (141490-22-4) ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1) ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24) ; PTEN Phosphohydrolase (EC 3.1.3.67) ; PTEN protein, human (EC 3.1.3.67) ; rhoB GTP-Binding Protein (EC 3.6.5.2)
    Language English
    Publishing date 2013-02-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-12-3325
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling.

    Di Martino, Maria T / Arbitrio, Mariamena / Guzzi, Pietro H / Leone, Emanuela / Baudi, Francesco / Piro, Eugenio / Prantera, Tullia / Cucinotto, Iole / Calimeri, Teresa / Rossi, Marco / Veltri, Pierangelo / Cannataro, Mario / Tagliaferri, Pierosandro / Tassone, Pierfrancesco

    British journal of haematology

    2011  Volume 154, Issue 4, Page(s) 529–533

    MeSH term(s) Aged ; Aged, 80 and over ; Bone Density Conservation Agents/adverse effects ; Case-Control Studies ; Diphosphonates/adverse effects ; Gene Frequency ; Genetic Predisposition to Disease ; Humans ; Imidazoles/adverse effects ; Jaw Diseases/genetics ; Middle Aged ; Multiple Myeloma/genetics ; Osteonecrosis/genetics ; PPAR gamma/genetics ; Polymorphism, Single Nucleotide ; Zoledronic Acid
    Chemical Substances Bone Density Conservation Agents ; Diphosphonates ; Imidazoles ; PPAR gamma ; Zoledronic Acid (6XC1PAD3KF)
    Language English
    Publishing date 2011-04-26
    Publishing country England
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/j.1365-2141.2011.08622.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

    Di Martino, Maria T / Leone, Emanuela / Amodio, Nicola / Foresta, Umberto / Lionetti, Marta / Pitari, Maria R / Cantafio, Maria E Gallo / Gullà, Annamaria / Conforti, Francesco / Morelli, Eugenio / Tomaino, Vera / Rossi, Marco / Negrini, Massimo / Ferrarini, Manlio / Caraglia, Michele / Shammas, Masood A / Munshi, Nikhil C / Anderson, Kenneth C / Neri, Antonino /
    Tagliaferri, Pierosandro / Tassone, Pierfrancesco

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2012  Volume 18, Issue 22, Page(s) 6260–6270

    Abstract: Purpose: Deregulated expression of miRNAs has been shown in multiple myeloma (MM). A promising strategy to achieve a therapeutic effect by targeting the miRNA regulatory network is to enforce the expression of miRNAs that act as tumor suppressor genes, ... ...

    Abstract Purpose: Deregulated expression of miRNAs has been shown in multiple myeloma (MM). A promising strategy to achieve a therapeutic effect by targeting the miRNA regulatory network is to enforce the expression of miRNAs that act as tumor suppressor genes, such as miR-34a.
    Experimental design: Here, we investigated the therapeutic potential of synthetic miR-34a against human MM cells in vitro and in vivo.
    Results: Either transient expression of miR-34a synthetic mimics or lentivirus-based miR-34a-stable enforced expression triggered growth inhibition and apoptosis in MM cells in vitro. Synthetic miR-34a downregulated canonic targets BCL2, CDK6, and NOTCH1 at both the mRNA and protein level. Lentiviral vector-transduced MM xenografts with constitutive miR-34a expression showed high growth inhibition in severe combined immunodeficient (SCID) mice. The anti-MM activity of lipidic-formulated miR-34a was further shown in vivo in two different experimental settings: (i) SCID mice bearing nontransduced MM xenografts; and (ii) SCID-synth-hu mice implanted with synthetic 3-dimensional scaffolds reconstituted with human bone marrow stromal cells and then engrafted with human MM cells. Relevant tumor growth inhibition and survival improvement were observed in mice bearing TP53-mutated MM xenografts treated with miR-34a mimics in the absence of systemic toxicity.
    Conclusions: Our findings provide a proof-of-principle that formulated synthetic miR-34a has therapeutic activity in preclinical models and support a framework for development of miR-34a-based treatment strategies in MM patients.
    MeSH term(s) Animals ; Apoptosis ; Cell Line ; Cell Proliferation ; Genes, Tumor Suppressor ; Genetic Therapy ; Humans ; Lentivirus/genetics ; Male ; Mice ; Mice, SCID ; MicroRNAs/biosynthesis ; MicroRNAs/genetics ; Multiple Myeloma/genetics ; Multiple Myeloma/pathology ; Multiple Myeloma/therapy ; Neoplasm Transplantation ; RNA Interference ; Transduction, Genetic ; Transfection ; Tumor Burden ; Tumor Microenvironment
    Chemical Substances MIRN34 microRNA, human ; MicroRNAs
    Language English
    Publishing date 2012-10-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-12-1708
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top